Evidence map›Paper›PMID 32607516›Full record

ArticlemedRxiv : the preprint server for health sciences2020

Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance.

Daniel B Larremore, Bryan Wilder, Evan Lester, Soraya Shehata, James M Burke, James A Hay, Tambe Milind, Michael J Mina, Roy Parker

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 294 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Daniel B LarremoreDepartment of Computer Science, University of Colorado Boulder.
Bryan WilderCenter for Research on Computation & Society, Harvard John A Paulson School of Engineering and Applied Sciences, Harvard University.
Evan LesterDepartment of Biochemistry, University of Colorado Boulder.
Soraya ShehataDepartment of Molecular, Cellular and Developmental Biology, University of Colorado.
James M BurkeDepartment of Biochemistry, University of Colorado Boulder.
James A HayCenter for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health.
Tambe MilindCenter for Research on Computation & Society, Harvard John A Paulson School of Engineering and Applied Sciences, Harvard University.
Michael J MinaCenter for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health.
Roy ParkerDepartment of Molecular, Cellular and Developmental Biology, University of Colorado.
University of Colorado Boulder · USHarvard University · USBrigham and Women's Hospital · USCenter for Disease Dynamics, Economics & Policy · USHoward Hughes Medical Institute · US

Funding

Deconvolution and reconstruction of immune histories to enhance infectious disease prevention and vaccination strategies and optimize surveillance effortsDP5OD028145 · OD · HARVARD SCHOOL OF PUBLIC HEALTH · PI HOFMAN, ALBERT · 2019 to 2021
$1.2M
Determining the specificity and biological functions of widespread host mRNA degradation by RNase LF32AI145112 · NIAID · UNIVERSITY OF COLORADO · PI BURKE, JAMES M · 2019 to 2021
$200k
The Role of RNA in Tau AggregationF30AG063468 · NIA · UNIVERSITY OF COLORADO · PI LESTER, EVAN T · 2019 to 2022
$154k
NIAID NIH HHS F32 AI145112NIA NIH HHS F30 AG063468NIH HHS DP5 OD028145
6 · The paper itself

Abstract

The COVID-19 pandemic has created a public health crisis. Because SARS-CoV-2 can spread from individuals with pre-symptomatic, symptomatic, and asymptomatic infections, the re-opening of societies and the control of virus spread will be facilitated by robust surveillance, for which virus testing will often be central. After infection, individuals undergo a period of incubation during which viral titers are usually too low to detect, followed by an exponential viral growth, leading to a peak viral load and infectiousness, and ending with declining viral levels and clearance. Given the pattern of viral load kinetics, we model surveillance effectiveness considering test sensitivities, frequency, and sample-to-answer reporting time. These results demonstrate that effective surveillance depends largely on frequency of testing and the speed of reporting, and is only marginally improved by high test sensitivity. We therefore conclude that surveillance should prioritize accessibility, frequency, and sample-to-answer time; analytical limits of detection should be secondary.

Identifiers

PMID32607516
PMCPMC7325181
OpenAlexW3037781831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.